Published in Gut on September 06, 2006
Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology (2009) 2.13
Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis (2009) 2.10
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol (2008) 1.78
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol (2012) 1.22
Lipids and HCV. Semin Immunopathol (2012) 1.19
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses (2013) 1.12
Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One (2009) 1.00
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98
Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health (2013) 0.96
Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail (2009) 0.94
Metabolic alterations and hepatitis C: From bench to bedside. World J Gastroenterol (2016) 0.91
Metabolic investigations in patients with hepatitis B and C. World J Gastroenterol (2010) 0.89
Acute hepatitis C infection lowers serum lipid levels. J Viral Hepat (2011) 0.87
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. J Viral Hepat (2011) 0.85
Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection. Gastroenterol Hepatol (N Y) (2016) 0.83
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. Hepat Mon (2011) 0.82
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World J Gastroenterol (2015) 0.82
Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int (2013) 0.82
Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature. Dig Dis Sci (2014) 0.80
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES. BMC Infect Dis (2015) 0.80
Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection. Hum Genet (2012) 0.79
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World J Gastroenterol (2014) 0.76
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol (2017) 0.75
Links between triglyceride levels, hepatitis C virus infection and diabetes. Gut (2007) 0.75
Do high lipids help clearance of hepatitis C? Gut (2007) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med (1999) 6.50
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A (1999) 6.05
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med (2000) 4.83
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology (2004) 4.16
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J (2002) 3.06
Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol (1994) 2.58
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol (1993) 2.36
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology (2006) 2.26
Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology (2001) 2.19
Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg (2002) 2.12
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol (2001) 1.98
Hepatitis C virus infection and incident type 2 diabetes. Hepatology (2003) 1.89
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg (1996) 1.86
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology (2000) 1.68
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J (2006) 1.52
Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol (1999) 1.50
Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology (1997) 1.49
Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc (2000) 1.48
Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol (2003) 1.32
Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (2000) 1.22
Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol (2005) 1.19
Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol (1992) 1.18
Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol (2002) 1.17
Hepatitis C and steatosis: a reappraisal. J Viral Hepat (2006) 1.16
Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol (2002) 1.11
Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology (2004) 1.04
C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. The ETDRS Research Group. Ann Epidemiol (1993) 0.98
Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. Am J Gastroenterol (2001) 0.92
Hepatitis C: a metabolic liver disease. Gastroenterology (2004) 0.88
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Assessing equity in access to health care provision in the UK: does where you live affect your chances of getting a coronary artery bypass graft? J Epidemiol Community Health (1995) 2.86
Ethnicity as an epidemiological determinant--crudely racist or crucially important? Int J Epidemiol (2001) 2.75
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA (2001) 2.63
Rise in childhood obesity with persistently high rates of undernutrition among urban school-aged Indo-Asian children. Arch Dis Child (2007) 2.57
Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat (2012) 2.28
Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology (2001) 2.19
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Equity in the NHS. Monitoring and promoting equity in primary and secondary care. BMJ (1994) 2.13
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia (2006) 1.90
Oil pollution: persistence and degradation of spilled fuel oil. Science (1972) 1.88
Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol (1993) 1.78
Cardiovascular disease mortality in relation to childhood and adulthood socioeconomic markers in British South Asian men. Heart (2007) 1.73
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med (1998) 1.72
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol (1993) 1.65
Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2004) 1.64
Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology (2000) 1.58
Assessment of intraocular pressure by palpation. Am J Ophthalmol (1995) 1.58
Higher clearance of hepatitis C virus infection in females compared with males. Gut (2006) 1.57
HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat (2012) 1.53
Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart (2004) 1.52
Developing risk stratification charts for diabetic and nondiabetic subjects. Diabet Med (1999) 1.48
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. Diabetologia (2011) 1.46
Peak selection from MALDI-TOF mass spectra using ant colony optimization. Bioinformatics (2007) 1.44
Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS (2001) 1.36
Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia (2005) 1.35
Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg (2001) 1.33
Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg (2000) 1.33
Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia (2001) 1.32
Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A (1992) 1.27
CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART). Clin Exp Immunol (2006) 1.26
Repeated measures in clinical trials: simple strategies for analysis using summary measures. Stat Med (2000) 1.25
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med (2002) 1.24
An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet Med (2011) 1.23
Social cognition in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev (2009) 1.22
Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. Heart (2007) 1.19
Birth weight, childhood growth and abdominal obesity in adult life. Int J Obes Relat Metab Disord (2002) 1.18
Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis (1997) 1.17
Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med (1998) 1.13
A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol Genet Metab (2009) 1.12
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia (2009) 1.11
Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism (2000) 1.10
Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol (1992) 1.09
Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys (1994) 1.07
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol (1990) 1.07
Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey. East Mediterr Health J (2013) 1.07
Gender differences in accessing cardiac surgery across England: a cross-sectional analysis of the health survey for England. Soc Sci Med (1998) 1.04
Assessment of tobacco dependence in waterpipe smokers in Egypt. Int J Tuberc Lung Dis (2012) 1.03
The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol (2003) 1.02
pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J Neurochem (1993) 1.01
HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut (2010) 1.00
Median analysis of blood pressure for a sample including treated hypertensives. Stat Med (1994) 0.99
HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Hum Retroviruses (1997) 0.99
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med (2011) 0.98
Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. Am J Trop Med Hyg (2001) 0.97
Factors associated with obesity in South Asian, Afro-Caribbean and European women. Int J Obes Relat Metab Disord (1999) 0.97
Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan. Diabet Med (2004) 0.96
Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med (2005) 0.95
Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis (2004) 0.95
Ethnic differences in retinal microvascular structure. Diabetologia (2008) 0.94
Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest (2002) 0.94
MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients. J Viral Hepat (2010) 0.93
Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension (1995) 0.92
Ethnicity-specific obesity cut-points in the development of Type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom. Diabet Med (2014) 0.92
Increase in tuberculosis incidence among the staff working at the Tuberculosis Demonstration and Training Centre in Addis Ababa, Ethiopia: a retrospective cohort study (1989-1998). Int J Tuberc Lung Dis (2002) 0.92
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS). Diabetologia (2008) 0.92
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev (2000) 0.91
Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect (2012) 0.91
Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes. Diabet Med (2006) 0.91
Identification of a site for a cohort study on natural history of HIV infection in Ethiopia. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.91
Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg (2001) 0.91
Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J Thromb Haemost (2007) 0.90
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2012) 0.90
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity. Eur Psychiatry (2011) 0.90
Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors. Vision Res (1998) 0.90
13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues. Environ Health Perspect (1998) 0.89
Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia (2008) 0.89
Effects of methyl mercury on testicular functions in Macaca fascicularis monkeys. Pharmacol Toxicol (1987) 0.88
Phytol-derived C19 di- and triolefinic hydrocarbons in marine zooplankton and fishes. Biochemistry (1969) 0.87